CTI BioPharma (CTIC) Misses Q4 EPS by 4c
Tweet
Share
E-mailGet Alerts CTIC Hot Sheet
Price: $9.09 --0%
Revenue Growth %: -100.0%
Financial Fact:
Loss from operations: -28.66M
Today's EPS Names:
NLY, CP, RUSHA, More
Revenue Growth %: -100.0%
Financial Fact:
Loss from operations: -28.66M
Today's EPS Names:
NLY, CP, RUSHA, More
Join SI Premium – FREE
CTI BioPharma (NASDAQ: CTIC) reported Q4 EPS of ($0.33), $0.04 worse than the analyst estimate of ($0.29).
For earnings history and earnings-related data on CTI BioPharma (CTIC) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- O'Reilly Automotive (ORLY) Misses Q1 EPS by 7c, Offers Guidance
- Universal Health Realty (UHT) Reports Q1 EPS of $0.38
- ATN International (ATNI) Misses Q1 EPS by 46c ; Offers Guidance
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
